Back to User profile » Dr Qingyu Xu
Paper published by Dr Qingyu Xu:
Original Research
Efficacy and Safety of TACE Combined with Regorafenib Plus PD-1 Inhibitor in the Treatment of Hepatocellular Carcinoma After Sorafenib Resistance
Zou X, Xu Q, You R, Yin G
Journal of Hepatocellular Carcinoma 2023, 10:267-279
Published Date: 16 February 2023